Clinical Trials on Virus Disease

Total 378284 results

Institute of Tropical Medicine, Belgium

Completed

Persistence of Zika Virus in Semen After Acute Infection

Transmission | Zika Virus | Zika Virus Disease | Virus Shedding

Belgium
Takeda

Completed

Safety, Immunogenicity, and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy Participants

Flavivirus Infections | Healthy Participants | Virus, Zika | Zika Virus Disease

United States, Puerto Rico
U.S. Army Medical Research and Development Command

Active, not recruiting

Combination HTNV and PUUV DNA Vaccine

Hantaan Virus Disease, Puumala Virus

United States
Emergent BioSolutions

Completed

Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG)

Zika Virus Infection | Zika Virus Disease

Canada
AstraZeneca

Completed

Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy Participants

Corona Virus Disease

United States
Sanofi Pasteur, a Sanofi Company

Completed

Zika Case Definition and Surveillance Study

Zika Virus Disease

Colombia, Honduras, Mexico, Puerto Rico
Hawaii Biotech, Inc.

Completed

Safety Study of HBV-002 West Nile Vaccine in Healthy Adults

West Nile Virus Disease

United States
Albert B. Sabin Vaccine Institute
Biomedical Advanced Research and Development Authority

Not yet recruiting

Monovalent Chimpanzee Adenoviral-Vectored Sudan Ebolavirus Vaccine in Healthy Adults

Ebola Sudan Virus Disease

Uganda, Kenya
International AIDS Vaccine Initiative
Biomedical Advanced Research and Development Authority

Active, not recruiting

Evaluation of Safety and Immunogenicity of rVSVΔG-SEBOV-GP Vaccine in Adults With Good General Health

Ebola Sudan Virus Disease

United States
Dana-Farber Cancer Institute

Active, not recruiting

Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes

BK Virus Infection

United States
Ology Bioservices

Completed

Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine

Ross River Virus Disease (RRVD)

Netherlands, Austria, Belgium
RTI International
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaborators

Completed

Zika in Infants and Pregnancy (ZIP)

Zika Virus Disease (Disorder)

Colombia, Brazil, Guatemala, Nicaragua, Peru, Puerto Rico
Columbia University

Recruiting

R-MVST Cells for Treatment of Viral Infections

BK Virus Infection | Epstein-Barr Virus Infections | Cytomegalovirus Infections | Adenovirus

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating an Ebola and a Marburg Vaccine in Uganda

Ebola Virus Disease | Marburg Virus Disease

Uganda
National Institute of Allergy and Infectious Diseases...

Completed

Investigational Therapeutics for the Treatment of People With Ebola Virus Disease

Ebola Virus

United States, Congo, The Democratic Republic of the
Chimerix

Withdrawn

An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus Disease (CMX)

Ebola Virus
Cerus Corporation

Terminated

A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease

Acute Ebola Virus Disease

United States
AlloVir

Completed

Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant (Prevent)

BK Virus Infection | Epstein-Barr Virus Infections | Cytomegalovirus Infections | Adenovirus Infection | JC Virus Infection | Human Herpes Virus-6 Infection

United States
AlloVir

Terminated

Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant (Prevent)

BK Virus Infection | Epstein-Barr Virus Infections | Cytomegalovirus Infections | Adenovirus Infection | JC Virus Infection | Human Herpes Virus-6 Infection

Korea, Republic of, United States, Spain, France, Turkey, Australia, United Kingdom, Italy, Canada, Belgium
Marius Henriksen

Terminated

Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure (TOCIVID)

Corona Virus Disease

Denmark
GlaxoSmithKline

Completed

A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

Chickenpox | Chicken-pox Illness (Varicella Virus Disease)

Estonia, Thailand, Germany, Mexico, United Kingdom
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China

Influenza A Virus Infection | Influenza B Virus Infection

China
National Institutes of Health Clinical Center (CC)

Completed

Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)

Dengue Virus | Zika Virus | Chikungunya Virus Infections

United States
GlaxoSmithKline

Recruiting

A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus (RSV) Given to Adults 18 to 49 Years of Age at Increased Risk for Respiratory Syncytial Virus Disease, Compared to Older Adults 60 Years of Age and Above

Respiratory Syncytial Virus Infections

Canada, Australia, United States, Germany, Japan, South Africa
National Institute of Allergy and Infectious Diseases...
US Military HIV Research Program

Completed

cAd3-Marburg Vaccine in Healthy Adults

Marburg Virus Disease

United States
Washington University School of Medicine

Not yet recruiting

Evaluating the Human Immune Response to the JYNNEOS Vaccine

Virus Diseases | Vaccinia

United States
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and Toddlers

Respiratory Syncytial Virus Infections

United States, Finland, Ghana, Honduras, India, Spain, Thailand
Labo'Life

Recruiting

Study to Evaluate the Efficacy of 2LEBV® and 2LXFS® on Asthenia in Patients With an Epstein-Barr Virus Infection (EBVAST)

EBV Infection

Belgium
National Institute of Allergy and Infectious Diseases...

Completed

Experimental Vaccine for Prevention of Ebola Virus Infection

Ebola Virus Disease | Ebola Hemorrhagic Fever | Ebola Virus Vaccines | Envelope Glycoprotein, Ebola Virus | Filovirus

United States
Albert B. Sabin Vaccine Institute
Biomedical Advanced Research and Development Authority

Active, not recruiting

Monovalent Chimpanzee Adenoviral-Vectored Marburg Virus Vaccine in Healthy Adults

Marburg Virus Disease

Uganda, Kenya
BioCryst Pharmaceuticals
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430

Marburg Virus Disease

United States
University of Lahore

Completed

Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins

Corona Virus Disease 2019 (COVID-19)

Pakistan
Beijing 302 Hospital
Maternal and Child Health Hospital of Hubei Province; Huoshenshan Hospital; VCANBIO... and other collaborators

Completed

Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)

Corona Virus Disease 2019(COVID-19)

China
National Institute of Allergy and Infectious Diseases...

Completed

Ebola and Marburg Virus Vaccines

Ebola Virus Disease | Ebola Vaccines | Marburg Virus Disease | Marburgvirus | Ebolavirus

United States
Qiu Li

Recruiting

Hepatitis B Virus Infection in Immunized Children With HBsAg-positive Parents

Hepatitis b Virus Infection

China
Marshfield Clinic Research Foundation
University of Wisconsin, Madison; Centers for Disease Control and Prevention

Completed

Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents

Influenza A Virus Infection | Influenza B Virus Infection | Immune Response to Influenza Vaccine

United States
Pascoe Pharmazeutische Praeparate GmbH
Dr. Loges & Co. GmbH

Completed

Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of Shingles (168)

Virus Diseases | Herpes Zoster

Germany
National Institute of Allergy and Infectious Diseases...

Completed

Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr Virus

Healthy | Epstein Barr Virus Infection

United States
Calmy Alexandra
Oswaldo Cruz Foundation; ANRS, Emerging Infectious Diseases

Recruiting

Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease (UNITY)

Monkeypox | Mpox

Switzerland, Brazil, Argentina
Klinik für Kinder- und Jugendmedizin

Completed

EBV Infection as a Risk Factor for PTLD in Pediatric and Adult Renal Transplant Recipients

Epstein-Barr Virus Infections

Germany
U.S. Army Medical Research and Development Command

Completed

A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA Vaccine

Hantaan Virus

United States
The Center for the Biology of Chronic Disease

Completed

A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin

Epstein-Barr Virus Infections | Cytomegalovirus Infections | Human Papillomavirus | Herpes Simplex Infections | Varicella-zoster Virus Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents (DNA)

RNA Virus Infections | Virus Diseases | Flavivirus Infections | Flaviviridae Infections | Zika Virus Infection | Zika Virus | Flaviviral Diseases

United States, Puerto Rico, Mexico, Brazil, Colombia, Costa Rica, Ecuador, Panama, Peru
Pfizer

Recruiting

A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection

Respiratory Syncytial Virus Infection

United States, Japan, China, Canada
Janssen Sciences Ireland UC

Terminated

A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection

Virus Diseases | Respiratory Syncytial Virus Infections

Australia, Spain, Belgium, Sweden, Netherlands, Brazil, Germany, Argentina, Philippines, United States
National Institute of Allergy and Infectious Diseases...

Suspended

Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein

Ebola Virus Disease

United States
Children's Hospital of Fudan University

Completed

Immunodeficiency for Severe Epstein-Barr Virus Infection

Epstein-Barr Virus Infections | Immunodeficiency

China
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine

Virus Diseases | Parainfluenza

United States
Merck Sharp & Dohme LLC

Completed

ZOSTAVAX(R) Local Registration Trial (V211-019)

Varicella Virus Infection
Valneva Austria GmbH
Emergent BioSolutions

Completed

Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy Adults

Zika Virus Infection | Zika Virus

United States

Clinical Trials on Virus Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations